Univar's pharma division adds DMV International's high performance excipients to its product range
Univar's Pharma division, formerly known as the pharmaceutical division of Anstead International and a leading distributor of ingredients to the pharmaceutical industry in the UK, announced that it is extending its distribution agreement with DMV International to incorporate its high performance disintegrants: Primojel and Primellose.
DMV recently added these to its existing product range and will use Univar Pharma's unrivalled customer base to market these excipients in the UK and Ireland.
Primojel is a sodium starch glycolate, one of a class of well established super disintegrants used in the manufacture of solid dosage forms.
It complies with the latest editions of the PhEur, USP/NF (sodium starch glycolate type A and B), JPE.
It takes more than 20 times its weight in water and the resulting high swelling capacity combined with high water penetration account for its high disintegration rate and efficiency. Primellose is a cross-linked carboxymethylcellulose sodium.
The cross-linking of this super disintegrant reduces its water solubility and permits the material to swell and take up many times its weight in water without loosing its fibrous integrity. Both products have been produced for many years and have an excellent performance history.
"This is an exciting addition to our range" comments Jeremy Drummond, Univar's pharmaceutical business manager.
"We are looking forward to developing this new product range supported by DMV's long-standing commitment to the highest standards of pharmaceutical quality.
